title: An epidemiology and molecular genetic study on breast cancer susceptibility.
abstract: OBJECTIVE
  To investigate the genetic susceptibility for breast cancer of Chinese, a hospital-based case-control study, pedigree survey and molecular genetic study were conducted.
  
  
  METHODS
  Logistic regression model and stratification methods were used in the risk factors analysis. Li-Mantel-Gart and Falconer methods were used to analyse the segregation ratio and heritability. Polymerase chain reaction (PCR) and polyacrylamide gel electrophoresis were used to detect AI, G-binding technique was used to detect the chromosome aberration of peripheral blood lymphocyte.
  
  
  RESULTS
  Family history of breast cancer is related to enhanced breast cancer risk significantly, OR is 3.905 (95% CI = 1.079 approximately 14.13), and it widely interacts with other risk factors. Accumulative incidence of breast cancer in first degree relatives is 9.99%, which is larger than that in second, third degree and non-blood relatives. Segregation ratio is 0.021, heritability among first degree relatives is 35.6 +/- 5.8%. Frequencies of LOH at BRCA1 and BRCA2 loci in sporadic breast cancer are 6.12% and 5.77% respectively. In the sibs, both of them show LOH at D13S173 locus, and high frequencies of chromosome aberrations were observed.
  
  
  CONCLUSIONS
  Genetic susceptibility contributes to breast cancer occurrence of Chinese, and its racial variation may be one of the important reasons for the large difference of incidence between western and eastern countries.
authors.affiliation: Laboratory of Biological Effect, Institute of radiation Medicine, CAMS & PUMC, Tianjin 300192.
authors.forename: W
authors.initials: W
authors.lastname: Ju
authors.forename: J
authors.initials: J
authors.lastname: Wang
authors.forename: B
authors.initials: B
authors.lastname: Li
authors.forename: Z
authors.initials: Z
authors.lastname: Li
mesh_terms: D000328:Adult; D044466:Asian People; D001943:Breast Neoplasms / Q000453:epidemiology / Q000235:genetics*; D016022:Case-Control Studies; D002681:China / Q000453:epidemiology; D005260:Female; D019398:Genes, BRCA1; D024522:Genes, BRCA2; D020022:Genetic Predisposition to Disease; D005820:Genetic Testing; D006801:Humans; D016015:Logistic Models; D019656:Loss of Heterozygosity; D008875:Middle Aged